- Aug. 13, 2022
-- The Global Cardiac Resynchronization Therapy (CRT) Devices Market was valued at USD 7.14 Billion in the year 2021 with the Americas region leading the regional market share. One of the main factors driving this market is the rising prevalence of cardiovascular diseases (CVDs) that lead to heart failure (HF). Each year, approximately 3.5 million people suffer from HF worldwide fostering the demand for cardiac resynchronization therapy devices. Additionally, factors such as technological advancements in devices, expanding CRT product developments, key company initiatives & investments, sedentary lifestyles and ageing demographics around the world are anticipated to impel the market growth in the forecast period.Scope of the Report
For more Information:https://azothanalytics.com/report/healthcare-and-pharmaceutical/global-cardiac-resynchronization-therapy-crt-devices-market-analysis-by-product-crt-d-crt-p-end-user-by-region-by-country-2022-edition-market-insights-and-forecast-with-impact-of-covid-19-2022-2027
- The report analyses the Cardiac Resynchronization Therapy Devices Market by Value (USD Billion).
- The report analyses the Cardiac Resynchronization Therapy Devices Market by Volume (in Million Units).
- The report analyses the Cardiac Resynchronization Therapy Devices Market by Product (CRT-Defibrillator and CRT-Pacemaker)
- The report analyses the Cardiac Resynchronization Therapy Devices Market by End User (Hospitals, Cardiac Centers and Research & Laboratories)
- The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Region (Americas, Europe, Asia Pacific, MEA).
- The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
- The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Product and by End User.
- Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The report tracks competitive developments, strategies, and Major Products & Developments and Mergers & Acquisitions. The companies analysed in the report include Medtronic, Boston Scientific Corp., Abbott Laboratories, Biotronik, MicroPort Scientific Corporation, Medico S.p.A, LivaNova and EBR Systems.
- The report presents the analysis of the Cardiac Resynchronization Therapy Devices Market for the historical period of 2017-2021 and the forecast period of 2022-2027.
(Business Development Manager)
Address: CS - 55, Third Floor, Ansal Plaza,
Tel: +91-120- 4298235
Mail ID - email@example.com